Share This Author
The health and economic effects of counterfeit drugs.
- E. Blackstone, J. Fuhr, Stephen Pociask
- Political Science, MedicineAmerican health & drug benefits
- 1 June 2014
The health and economic consequences of counterfeit drugs on the US public and on the healthcare system as a whole are reviewed to reduce the incentive to engage in research and development and innovation.
Redefining Health Care: Creating Value-Based Competition on Results
Cost–Benefit Analysis of Chlorhexidine Gluconate Dressing in the Prevention of Catheter-Related Bloodstream Infections
Chlorhexidine dressings would reduce costs, local infections and CRBSIs, and deaths and should be considered to prevent infections among patients with catheters.
The Economics of Medicare Accountable Care Organizations.
BACKGROUND Accountable care organizations (ACOs) have been created to improve patient care, enhance population health, and reduce costs. Medicare in particular has focused on ACOs as a primary device…
Diagnosing Crohn's disease: an economic analysis comparing wireless capsule endoscopy with traditional diagnostic procedures.
Comparing the costs of a diagnostic algorithm incorporating wireless capsule endoscopy (WCE) with the current algorithm for diagnosing Crohn's disease suspected in the small bowel shows that Employing WCE as a first-line diagnostic procedure appears to be less costly, from a payor perspective, than current common procedures fordiagnosing suspected Crohn’s disease in theSmall bowel.
Broadband and Telecommuting: Helping the U.S. Environment and the Economy
This study examines how to reduce greenhouse gas emissions in the U.S. through the widespread delivery of broadband services and the expansion of telecommuting. Telecommuting can reduce greenhouse…
Innovation and Competition: Will Biosimilars Succeed?: The creation of an FDA approval pathway for biosimilars is complex and fraught with hazard. Yes, innovation and market competition are at stake.…
Biosimilars are here, but there's no clear pathway yet for their approval. Difficult realities about their effect on drug prices, innovation, and competition need to be faced.
Economic implications of non-adherence to treatment recommendations for hemodialysis patients with anemia
Comparing actual use of EPO and intravenous iron with that recommended in KDOQI guidelines provides incentive for payers and dialysis centers to examine their current practices and improve the quality and efficiency of anemia treatment in this population.
An antitrust analysis of non-profit hospital mergers
This paper considers such issues involved in non-profit hospital mergers as relevant product and geographic markets and the impacts of mergers on competition. The roles of non-price competition,…
Comparative effectiveness of total population versus disease-specific neural network models in predicting medical costs.
Two neural network models-a population model and three disease-specific models-were compared regarding effectiveness predicting high costs; in general, the larger the cohort, the greater the advantage in predictive power of the disease model compared to the population model.